Frequently Asked Questions

Taama is an AI-powered regulatory compliance platform for food and supplement brands, regulatory consultants, and retailers. It validates ingredient permissibility, determines the correct regulatory classification and go-to-market pathway, checks label and packaging compliance, confirms registration dossier completeness, and verifies document validity — across 18 markets spanning APAC, Europe, and the Americas. Instead of weeks of manual regulatory research per market, brands get a structured compliance assessment in minutes.

Taama is built for three groups. Food and supplement brands use it to launch and manage products across multiple markets without a regulatory team in every country. Regulatory consultants and agencies use it to review products faster on behalf of clients and scale capacity without adding headcount. Retailers and supermarkets use it to assess supplier product risk before listing — checking ingredients, labels, and documentation in seconds rather than days.

Taama checks every dimension of product compliance in one assessment: ingredient permissibility, regulatory classification and go-to-market pathway, label and packaging compliance, registration dossier completeness, and document validity. Whether you're a brand launching into a new market, a consultant reviewing on behalf of a client, or a retailer assessing a supplier submission - all checks run across every target market simultaneously, so you see exactly what passes, what fails, and what is missing for each market.

Taama covers 18 markets. Twelve are live: Australia (TGA, FSANZ), New Zealand (FSANZ, MPI), Singapore (HSA, SFA), Indonesia (BPOM, MUI), Malaysia (NPRA, JAKIM), Philippines (FDA PH), the European Union (EFSA), Gulf/GCC (SFDA, ESMA), the United States (FDA, DSHEA), the United Kingdom (FSA, MHRA), Canada (Health Canada, NHP), and Mexico (COFEPRIS). China is coming soon, and Vietnam, Thailand, India, South Korea, and Japan are on the roadmap. If your market isn't covered yet, just ask, we add markets on demand.

Yes. Taama assesses a single product against multiple target markets in one assessment, with each market evaluated against its own regulatory framework - TGA in Australia, HSA in Singapore, BPOM in Indonesia, and so on. Compliance does not transfer between markets, so a product cleared in one country almost always needs changes for the next. Running markets in parallel shows you exactly where the product is ready and where it needs work, all at once.

Taama provides full TGA and FSANZ compliance coverage for Australia. For therapeutic goods, it determines the correct TGA pathway (AUST L, AUST L(A), or AUST R) and validates ingredient permissibility and permitted indications under the TGA's Permissible Indications Determination. For food-format products, it checks FSANZ label compliance including the Nutrition Information Panel format, allergen declarations, and nutrition and health claims. New Zealand has a dedicated module covering NZ-specific FSANZ requirements and MPI import documentation.

Taama covers supplement compliance in Singapore across both regulatory frameworks. It determines whether your product falls under the HSA (Health Sciences Authority) as a health supplement or the SFA (Singapore Food Agency) as a food — a classification that dictates notification pathway, permitted claims, and label requirements. It screens ingredient permissibility under HSA guidelines, runs MUIS halal screening where relevant, and validates label compliance including the mandatory 'This is not a medicinal product' advisory.

Taama covers BPOM registration for Indonesia end to end. It determines whether your product registers as MD (domestic) or ML (imported), screens ingredients against BPOM positive lists for health supplements, checks label compliance in Bahasa Indonesia, and confirms registration dossier completeness before submission — including stability data for tropical conditions and an apostilled certificate of free sale, two of the most common causes of BPOM rejection. MUI halal screening runs in parallel.

Taama covers halal compliance across Southeast Asia and the Gulf by screening ingredients at the formulation stage — before you invest in registration or certification. For Indonesia, it screens against MUI prohibited substance lists. For Malaysia, it checks against JAKIM halal standards under MS 1500. For Gulf/GCC markets, it applies GCC halal requirements alongside SFDA and ESMA classification rules. The most common halal failures (gelatin capsule shells, animal-derived magnesium stearate, carmine colourants, and alcohol-based excipients) are flagged early so you can reformulate before a certifying body rejects the product.

Taama covers FDA dietary supplement compliance for the US under DSHEA. It screens ingredients and flags any New Dietary Ingredient (NDI) that requires pre-market notification, classifies each claim as a permitted structure/function claim or a prohibited drug claim, validates the Supplement Facts panel format under 21 CFR Part 101, and reviews marketing claims against FTC substantiation standards. The structure/function versus drug claim line is where most US supplement brands run into enforcement trouble - Taama draws it clearly before launch.

We price based on what you use, not a fixed tier. Plans are scoped around your target markets, product catalogue, and team size — so you're not paying for coverage you don't need. Get in touch to discuss your requirements.

One product across one target market - all five check types included. A product targeting three markets uses three assessments. The Starter Plan includes 10 assessments per month.